Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Transplant Cell Ther. 2021 Jan 7;27(3):262.e1–262.e11. doi: 10.1016/j.jtct.2021.01.004

Figure 2. Cumulative incidence of bloodstream infections based on days relative to transplant.

Figure 2.

Cumulative incidence curves are plotted for clinically-significant BSIs (A, Gray’s Test p=0.02), LCBI (B, Gray’s Test p=0.18), CLABSI (C, Gray’s Test p=0.20), and MBI-LCBI (D, Gray’s Test p=0.03). Transplant day 0 corresponds to the day of stem cell infusion. Patients with greater CHG adherence experienced significantly reduced incidence of clinically significant BSI and MBI-LCBI.